SGI
ADMA icon

Summit Global Investments’s ADMA Biologics ADMA Stock Holding History

Summit Global Investments’s Portfolio ADMA Stock Details ADMA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$155K Buy
+18,505
New +$169K 0.01% 517
2025
Q3 		– Sell
-20,454
Closed -$372K – 465
2025
Q2 		$372K Sell
20,454
-43,360
-68% -$884K 0.02% 354
2025
Q1 		$1.27M Buy
63,814
+18,389
+40% +$318K 0.09% 131
2024
Q4 		$779K Buy
+45,425
New +$855K 0.05% 268

Other funds holding ADMA

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
RCMNY
Rubric Capital Management (New York) New York $10.9B AUM 70.31% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
First Trust Advisors
First Trust Advisors Wheaton, Illinois $170B AUM 46.21% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
CP
Caligan Partners New York $2.13B AUM 758.65% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Summit Global Investments's ADMA Position: Q2 2026 in Review

Summit Global Investments opened a new position in ADMA Biologics (ADMA) in Q2 2026: 18,505 shares worth $155K. The stake represents 0.01% of the portfolio and ranks #517 among its holdings. This is a return to the name: Summit Global Investments previously reported a position in ADMA as recently as Q2 2025.

Summit Global Investments first reported a position in ADMA in Q4 2024 and has held it in 4 quarters since. The position peaked at $1.27M in Q1 2025. 322 funds tracked by Wall St. Rank hold ADMA as of Q2 2026.

  • Summit Global Investments held 18,505 shares of ADMA Biologics worth $155K as of Q2 2026.
  • ADMA Biologics was a new Summit Global Investments position in Q2 2026.
  • ADMA Biologics made up 0.01% of Summit Global Investments's portfolio in Q2 2026, its #517 holding.
  • Summit Global Investments first reported a position in ADMA Biologics in Q4 2024 and has held it in 4 quarters since.
  • Summit Global Investments's ADMA Biologics position peaked at $1.27M in Q1 2025.
  • 322 funds tracked by Wall St. Rank held ADMA Biologics as of Q2 2026.

Based on Summit Global Investments's 13F filing for Q2 2026, filed 3 Aug 2026.